Tamayo Louis Edward
- SEC CIK
- 0002083206
In the past year, 2 open-market sale filings worth $41.0K and no purchases.
Current role at each company
- LXEO Lexeo Therapeutics, Inc.Chief Financial Officeras of Sep 28, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $41.0K
- 2 filings
- Net
- −$41.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Tamayo Louis Edward as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 (view filing)5:00 PM ET | Aug 18 | 1 day | Tamayo Louis EdwardChief Financial Officer | SSale | −4.12K | $4.91 | −$20.2K | −4.2%92.9K after | |
| Jul 1, 2026 (view filing)6:49 PM ET | Jul 1 | Same day | Tamayo Louis EdwardChief Financial Officer | SSale | −4.64K | $4.49 | −$20.8K | −4.6%97.0K after |